ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.873,13
-0,67%
S&P 500
5.713,64
1,70%
Dow Jones
42.025,19
0,00%
Euro vs US Dollar
1,1165
0,05%
Bitcoin
63.374,39
0,67%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Sana Biotechnology Inc (SANA)

  7. Sana Biotechnology Inc (SANA) News

SANA

Sana Biotechnology (SANA)

Sana Biotechnology Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:SANA
DatumZeitQuelleÜberschriftSymbolFirma
12/09/202422h36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
29/08/202422h05GlobeNewswire Inc.Sana Biotechnology to Present at September 2024 Investor ConferencesNASDAQ:SANASana Biotechnology Inc
26/08/202422h05GlobeNewswire Inc.Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific OfficerNASDAQ:SANASana Biotechnology Inc
08/08/202422h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SANASana Biotechnology Inc
08/08/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
08/08/202422h05GlobeNewswire Inc.Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business UpdatesNASDAQ:SANASana Biotechnology Inc
06/08/202412h30PR Newswire (US)Flagship Pioneering Announces Appointment of Raj Panjabi as Senior PartnerNASDAQ:SANASana Biotechnology Inc
15/07/202422h12Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:SANASana Biotechnology Inc
07/06/202422h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SANASana Biotechnology Inc
07/06/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
21/05/202415h00GlobeNewswire Inc.Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other GliaNASDAQ:SANASana Biotechnology Inc
08/05/202422h49Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SANASana Biotechnology Inc
08/05/202422h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SANASana Biotechnology Inc
08/05/202422h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
08/05/202422h05GlobeNewswire Inc.Sana Biotechnology Reports First Quarter 2024 Financial Results and Business UpdatesNASDAQ:SANASana Biotechnology Inc
06/05/202422h05GlobeNewswire Inc.Sana Biotechnology to Present at May and June 2024 Investor ConferencesNASDAQ:SANASana Biotechnology Inc
08/03/202422h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SANASana Biotechnology Inc
08/03/202422h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SANASana Biotechnology Inc
29/02/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
29/02/202422h05GlobeNewswire Inc.Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business UpdatesNASDAQ:SANASana Biotechnology Inc
28/02/202422h05GlobeNewswire Inc.Sana Biotechnology to Present at the Cowen 44th Annual Health Care ConferenceNASDAQ:SANASana Biotechnology Inc
14/02/202422h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SANASana Biotechnology Inc
13/02/202422h05GlobeNewswire Inc.Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHPNASDAQ:SANASana Biotechnology Inc
12/02/202422h05GlobeNewswire Inc.Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:SANASana Biotechnology Inc
08/02/202423h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
08/02/202422h49Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SANASana Biotechnology Inc
08/02/202407h22GlobeNewswire Inc.Sana Biotechnology Announces Pricing of Upsized Public OfferingNASDAQ:SANASana Biotechnology Inc
08/02/202403h59Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:SANASana Biotechnology Inc
07/02/202423h05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SANASana Biotechnology Inc
07/02/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
 Showing the most relevant articles for your search:NASDAQ:SANA

Kürzlich von Ihnen besucht

UNSW3
NOMEMEETH
NoMeme
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten